Mark S. Riddle

Public Health and Preventive Medicine
1500 E 2nd St Ste 302
Reno, NV 89502

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 203 publications

Deciphering the prodrome of inflammatory bowel disease up to 10 years before disease onset by massively parallel serology.

Deciphering the prodrome of inflammatory bowel disease up to 10 years before disease onset by massively parallel serology.

Journal: Gut
Published: December 08, 2025

Retrospective analysis of emerging health threats by shoreland Travax®, 2019-2024.

Retrospective analysis of emerging health threats by shoreland Travax®, 2019-2024.

Journal: Journal of travel medicine
Published: October 15, 2025

Tick-borne encephalitis in international travellers: a systematic review and vaccine recommendations.

Tick-borne encephalitis in international travellers: a systematic review and vaccine recommendations.

Journal: Journal of travel medicine
Published: July 05, 2025

Examining Practice Change Among Primary Care Providers Using a Child Psychiatry Access Program.

Examining Practice Change Among Primary Care Providers Using a Child Psychiatry Access Program.

Journal: Academic pediatrics
Published: February 13, 2025

Children in Mental Health Crisis: Pediatric Primary Care Providers' Role in Bridging Treatment Following Higher Levels of Care.

Children in Mental Health Crisis: Pediatric Primary Care Providers' Role in Bridging Treatment Following Higher Levels of Care.

Journal: Journal of clinical psychology in medical settings
Published: July 01, 2024

Efficacy Evaluation of an Intradermally Delivered Enterotoxigenic Escherichia coli CF Antigen I Fimbrial Tip Adhesin Vaccine Coadministered with Heat-Labile Enterotoxin with LT(R192G) against Experimental Challenge with Enterotoxigenic E. coli H10407 in Healthy Adult Volunteers.

Efficacy Evaluation of an Intradermally Delivered Enterotoxigenic Escherichia coli CF Antigen I Fimbrial Tip Adhesin Vaccine Coadministered with Heat-Labile Enterotoxin with LT(R192G) against Experimental Challenge with Enterotoxigenic E. coli H10407 in Healthy Adult Volunteers.

Journal: Microorganisms
Published: December 12, 2023

Gut microbiome and antibiotic resistance effects during travelers' diarrhea treatment and prevention.

Gut microbiome and antibiotic resistance effects during travelers' diarrhea treatment and prevention.

Journal: mBio
Published: December 12, 2023

Background incidence rates of health outcomes in populations at risk for Lyme disease using US administrative claims data.

Background incidence rates of health outcomes in populations at risk for Lyme disease using US administrative claims data.

Journal: Vaccine
Published: October 06, 2023

A First in Human Clinical Trial Assessing the Safety and Immunogenicity of Two Intradermally Delivered Enterotoxigenic Escherichia coli CFA/I Fimbrial Tip Adhesin Antigens with and without Heat-Labile Enterotoxin with Mutation LT(R192G).

A First in Human Clinical Trial Assessing the Safety and Immunogenicity of Two Intradermally Delivered Enterotoxigenic Escherichia coli CFA/I Fimbrial Tip Adhesin Antigens with and without Heat-Labile Enterotoxin with Mutation LT(R192G).

Journal: Microorganisms
Published: September 15, 2023

Advances on the forefront of travellers' diarrhoea.

Advances on the forefront of travellers' diarrhoea.

Journal: Journal of travel medicine
Published: August 28, 2023

Clinical and regulatory development strategies for Shigella vaccines intended for children younger than 5 years in low-income and middle-income countries.

Clinical and regulatory development strategies for Shigella vaccines intended for children younger than 5 years in low-income and middle-income countries.

Journal: The Lancet. Global health
Published: June 13, 2023

GMP manufacture of Shigella flexneri 2a Artificial Invaplex (InvaplexAR) and evaluation in a Phase 1 Open-label, dose escalating study administered intranasally to healthy, adult volunteers.

GMP manufacture of Shigella flexneri 2a Artificial Invaplex (InvaplexAR) and evaluation in a Phase 1 Open-label, dose escalating study administered intranasally to healthy, adult volunteers.

Journal: Vaccine
Published: May 12, 2023
Showing 1-12 of 203

Last Updated: 09/26/2026